During the last session, AxoGen Inc. (NASDAQ:AXGN)’s traded shares were 0.43 million, with the beta value of the company hitting 0.72. At the end of the trading day, the stock’s price was $9.40, reflecting an intraday gain of 6.09% or $0.54. The 52-week high for the AXGN share is $22.82, that puts it down -142.77 from that peak though still a striking 26.91% gain since the share price plummeted to a 52-week low of $6.87. The company’s market capitalization is $426.95M, and the average intraday trading volume over the past 10 days was 0.62 million shares, and the average trade volume was 344.05K shares over the past three months.
AxoGen Inc. (AXGN) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.90. AXGN has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.13.
AxoGen Inc. (NASDAQ:AXGN) trade information
AxoGen Inc. (AXGN) registered a 6.09% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 6.09% in intraday trading to $9.40 this Friday, 05/13/22, hitting a weekly high. The stock’s 5-day price performance is 4.10%, and it has moved by 25.00% in 30 days. Based on these gigs, the overall price performance for the year is -56.22%. The short interest in AxoGen Inc. (NASDAQ:AXGN) is 0.68 million shares and it means that shorts have 1.69 day(s) to cover.
The consensus price target of analysts on Wall Street is $18.80, which implies an increase of 50.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $14.00 and $25.00 respectively. As a result, AXGN is trading at a discount of -165.96% off the target high and -48.94% off the low.
AxoGen Inc. (AXGN) estimates and forecasts
Statistics show that AxoGen Inc. has underperformed its competitors in share price, compared to the industry in which it operates. AxoGen Inc. (AXGN) shares have gone down -26.10% during the last six months, with a year-to-date growth rate less than the industry average at -57.58% against 4.10. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -62.50% this quarter and then drop -37.50% in the quarter after that. In the rating firms’ projections, revenue will increase 13.80% compared to the previous financial year.
Revenue for the current quarter is expected to be $31.91 million as predicted by 7 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to $33.99 million by the end of Mar 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $32.49 million and $31.04 million respectively. In this case, analysts expect current quarter sales to shrink by -1.80% and then jump by 9.50% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -6.90%. While earnings are projected to return -10.00% in 2022.
AxoGen Inc. is due to release its next quarterly earnings between February 21 and February 25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
AxoGen Inc. (NASDAQ:AXGN)’s Major holders
AxoGen Inc. insiders own 4.64% of total outstanding shares while institutional holders control 80.12%, with the float percentage being 84.02%. ArrowMark Colorado Holdings LLC is the largest shareholder of the company, while 190 institutions own stock in it. As of Sep 29, 2021, the company held over 5.49 million shares (or 13.20% of all shares), a total value of $86.68 million in shares.
The next largest institutional holding, with 2.94 million shares, is of Blackrock Inc.’s that is approximately 7.07% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $46.41 million.
Also, the Mutual Funds coming in first place with the largest holdings of AxoGen Inc. (AXGN) shares are Vanguard Explorer Fund, Inc. and Janus Henderson Venture Fund. Data provided on Oct 30, 2021 indicates that Vanguard Explorer Fund, Inc. owns about 1.58 million shares. This amounts to just over 3.80 percent of the company’s overall shares, with a $23.97 million market value. The same data shows that the other fund manager holds slightly less at 1.24 million, or about 2.97% of the stock, which is worth about $19.53 million.